Latest Operating Expenses News

AVADA Group Limited reported a seasonally subdued quarter ending March 2025 but achieved positive operating cash flow through disciplined cost reductions and operational efficiencies. A strategic review of its New Zealand operations is underway amid challenging market conditions.

Arcadia Minerals is gearing up for a significant drilling campaign at its Karibib Copper Gold Project while navigating a competitive funding process for the Swanson Tantalum Mine. Strategic partnerships remain central to the company’s growth plans amid cautious lithium market conditions.

Peninsula Energy reported a $1.9 million operating cash outflow and $18.9 million investing spend on its Lance Project for Q1 2025, ending the quarter with $24.2 million in cash and an estimated 13 quarters of funding runway based on current outflows.

Hexima Limited reported a stable cash position of $1.55 million at quarter-end, with a modest $87,000 net cash outflow from operations. The biotech company continues to explore strategic opportunities while maintaining a strong funding runway.

Mustera Property Group advances its McCabe Street apartment project with a planned sales launch in Q3 2025, while settling $4.5 million in sales at Forbes Residences during the March quarter.

Activeport Group Ltd reported a robust 49.3% increase in software revenue for Q3 2025, driven by strategic wins across Asia and Australia, even as SaaS revenue declined due to restructuring. The company’s new technology deployments and cost-cutting measures position it for growth in the coming quarters.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

NoviqTech has advanced its blockchain-based sustainability solutions, pioneering real-world asset tokenisation and expanding its investor base through OTCQB trading in the US.

Cyprium Metals completed a A$15 million capital raise and formed a strategic alliance with Macmahon to accelerate the restart of its Nifty Copper Complex, while upgrading its Maroochydore copper-cobalt resource.

Elixinol Wellness reported a 13.7% year-on-year revenue increase in Q1 FY25, despite a softer quarter compared to record Q4, with ecommerce momentum and strategic initiatives setting the stage for margin recovery and growth in H2.